NCT04426201 2024-04-11
ILIAD-7-US-O
Revimmune
Phase 2 Terminated
Clinical Trials
5 trialsNCT04863248 2023-04-14
PRESERVE 4
G1 Therapeutics, Inc.
Phase 2 Terminated
NCT03122301 2022-08-09
Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer
Northwestern University
Phase 2 Terminated
NCT03241810 2020-09-02
SHERBOC
Elevation Oncology
Phase 2 Terminated
NCT02258464 2020-08-10
Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer
Bayer
Phase 2 Terminated